Form 4: Medpace Holdings Director Dani S. Zander Acquires Stock Options

Director Dani S. Zander acquired stock options in Medpace Holdings, Inc. on May 16, 2025.

Summary

• On May 16, 2025, Dani S. Zander, a director of Medpace Holdings, Inc., acquired 1,224 stock options at a price of $305.66.
• These options vest on the earlier of the day before the first annual meeting following the grant date or the first anniversary of the grant date, contingent upon continued service on the board.
• Following the transaction, Zander directly owns 1,224 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director. It doesn't inherently indicate positive or negative performance, but rather provides transparency.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency into the actions of company insiders, which can be informative for investors.

Stakeholder Impact

• Shareholders may view this transaction as a sign of confidence from a company director.

Key Dates

Keywords

Medpace Holdings, Director, Stock Options, Form 4, Zander, MEDP